| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/25/2004 | EP1390407A2 The lectin-like domain of thrombomodulin and its therapeutic use |
| 02/25/2004 | EP1390406A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 02/25/2004 | EP1390405A2 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 02/25/2004 | EP1390404A2 Interleukin-1 related gene and protein |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390402A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/25/2004 | EP1390400A2 Pharmaceutical use for secreted bacterial effector proteins |
| 02/25/2004 | EP1390399A2 Long lasting fusion peptide inhibitors for hiv infection |
| 02/25/2004 | EP1390393A2 Pentapeptide compounds and uses related thereto |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390390A2 Human secreted proteins |
| 02/25/2004 | EP1390388A1 Antisense modulation of interferon gamma receptor 1 expression |
| 02/25/2004 | EP1390387A2 Cancer-testis antigens |
| 02/25/2004 | EP1390386A1 Antisense modulation of phospholipid scramblase i expresion |
| 02/25/2004 | EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions |
| 02/25/2004 | EP1390383A1 Antisense permeation enhancers |
| 02/25/2004 | EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1390075A2 Chemotherapeutic induction of egr-1 promoter activity |
| 02/25/2004 | EP1390071A2 Symbiotic regenerative agent |
| 02/25/2004 | EP1390070A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 02/25/2004 | EP1390063A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 02/25/2004 | EP1390062A2 Modulators of elastase inhibitor secretion |
| 02/25/2004 | EP1390061A2 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 02/25/2004 | EP1390060A2 Use of lp82 to treat body weight disorders |
| 02/25/2004 | EP1390059A1 Improved neuronal gene transfer |
| 02/25/2004 | EP1390058A2 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1390056A2 Glycopeptide antibiotics |
| 02/25/2004 | EP1390055A2 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1390053A2 Hcg formulation |
| 02/25/2004 | EP1390052A1 Inhibition of jun kinase |
| 02/25/2004 | EP1390049A1 Compositions for treating animal diseases and syndromes |
| 02/25/2004 | EP1390046A2 Treatment of neoplasms with viruses |
| 02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
| 02/25/2004 | EP1390011A2 Control of compactability through crystallization |
| 02/25/2004 | EP1389941A2 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity |
| 02/25/2004 | EP1389915A2 The use of food and drink as a delevery system for phytase in humans |
| 02/25/2004 | EP1135481B1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 02/25/2004 | EP1064032B1 Material composition for the formation of tissue |
| 02/25/2004 | EP0981620B1 Hgf polypeptides and their use in therapy |
| 02/25/2004 | EP0969726B1 Treatment for dutch elm disease |
| 02/25/2004 | EP0967224B1 Fish protein, its gene, reagents for inducing apoptosis, and anticancer agents |
| 02/25/2004 | EP0948308B1 Methods for treating skin pigmentation |
| 02/25/2004 | EP0869976B1 Design of hormone-like antibodies with agonistic and antagonistic functions |
| 02/25/2004 | EP0866861B1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 02/25/2004 | EP0820515B1 Phospholipase c homolog |
| 02/25/2004 | EP0790059B1 Means for treating auto-immune diseases |
| 02/25/2004 | EP0759987B1 Antibody against human restrictin |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/25/2004 | EP0749478B1 Yeast strains and modified albumins |
| 02/25/2004 | EP0688210B1 Use of carnosine in combination with urocanic acid for treatment of photodermatoses |
| 02/25/2004 | EP0665888B1 Ryegrass pollen allergen |
| 02/25/2004 | CN1478146A Calcium binding proteins |
| 02/25/2004 | CN1478145A Differentiated cells suitable for human therapy |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1477975A Combination of GABA agonists and sorbitol dehydrogenase inhibitors |
| 02/25/2004 | CN1477969A Chemokine mutants in treatment of multiple sclerosis |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477964A Treatment of neoplasms with viruses |
| 02/25/2004 | CN1477950A Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of critically ill, chronically ill and people with malnutrition |
| 02/25/2004 | CN1477199A A polypeptide-human phosphatidase 14 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477198A A polypeptide-human RNA uncoiling enzyme 44 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477196A A polypeptide-CoA carboxylase 41 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477195A A polypeptide-human methionyl-tRNA synthetase 29 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477194A A polypeptide-human transpasase 105 and polynucleotide coding said polypetide |
| 02/25/2004 | CN1477193A Novel human Rab GTP enzyme, its coding sequence and application |
| 02/25/2004 | CN1477129A Recombinant vascular endothelial growth factor-diphtherin fusion protein, its preparation and application |
| 02/25/2004 | CN1477126A Long-acting growth hormone and medicine composition |
| 02/25/2004 | CN1477119A Novel Human cysteine proteinase inhibitor sample molecule, its coding sequence and application |
| 02/25/2004 | CN1477118A Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application |
| 02/25/2004 | CN1477117A Novel human phosphotidylethanolamine binding protein, its coding sequence and application |
| 02/25/2004 | CN1477116A Novel human secretion-related membrane protion, its coding sequence and its application |
| 02/25/2004 | CN1477115A Novel human cyclin, its coding sequence and application |
| 02/25/2004 | CN1477114A Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application |
| 02/25/2004 | CN1477113A Recombinant human fatty acid oxidation protein, its production method and application |
| 02/25/2004 | CN1476897A Preparation technique of protein medicine microsphere carrier with small grain size |
| 02/25/2004 | CN1476893A Medince composition containing huanzupulo for curing diabetes |
| 02/25/2004 | CN1139385C Method and composition for lipidization of hydrophilic molecules |
| 02/24/2004 | US6697837 End user profiling method |
| 02/24/2004 | US6697668 Ocular iontophoretic device and method for using the same |
| 02/24/2004 | US6696559 Antimicrobial peptides and methods of use |
| 02/24/2004 | US6696558 Bag proteins and nucleic acid molecules encoding them |
| 02/24/2004 | US6696557 Isolated nucleic acid comprising nucleotide sequence encoding extracellular domain of al-2 fused to immunoglobulin amino acid sequence |
| 02/24/2004 | US6696556 Genetic engineering |
| 02/24/2004 | US6696547 Mutant DEDD proteins for regulating apoptosis |
| 02/24/2004 | US6696546 Peptide that kills growing but not stationary cells |
| 02/24/2004 | US6696545 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 02/24/2004 | US6696493 Treating chronic uremic patients undergoing periodic dialysis |
| 02/24/2004 | US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure |
| 02/24/2004 | US6696438 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 02/24/2004 | US6696422 Parenterally administering product r, a peptide-nucleic acid preparation, in combination with one or more antiviral agents useful for treating aids or hiv infections including hiv protease inhibitors and nucleosides |
| 02/24/2004 | US6696418 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 02/24/2004 | US6696416 Synthetic multimer proteins comprising octapeptides used for suppression metastasis or tumors; anticarcinogenic agents |
| 02/24/2004 | US6696415 Tubedown-1 (tbdn-1), a protein associated with acetyltransferase activity has been characterized and its cdna isolated; tbdn-1 regulates endothelial differentiation through protein acetylation; angiogenesis inhibitors |
| 02/24/2004 | US6696414 Use of growth hormone in low dose |
| 02/24/2004 | US6696413 For oral administration to reduce nephrotoxicity and topically promote skin permeation in treatment of psoriasis |
| 02/24/2004 | US6696412 Purification of daptomycin by binding to ion exchange resins in the presence of buffers and chaotropic agents, then eluting and recovering; peptide antibiotics |